ALLERGOLOGY INTERNATIONAL
Scope & Guideline
Bridging gaps in allergy research and practice.
Introduction
Aims and Scopes
- Allergen Immunotherapy:
The journal consistently explores various aspects of allergen immunotherapy, including its efficacy, mechanisms, and applications in different allergic conditions such as asthma, rhinitis, and food allergies. - Food Allergies and Intolerance:
Research on food allergies, including non-IgE-mediated reactions, is a core focus, with studies investigating the clinical characteristics, epidemiology, and management strategies for conditions like food protein-induced enterocolitis syndrome. - Eosinophilic Disorders:
There is a significant emphasis on eosinophilic disorders, particularly in relation to asthma and chronic rhinosinusitis, examining the roles of eosinophils in inflammation and the efficacy of biologic treatments. - Genetic and Molecular Insights:
The journal features studies that delve into the genetic and molecular underpinnings of allergic diseases, including investigations into specific biomarkers and genetic predispositions that influence disease severity and treatment outcomes. - Clinical Guidelines and Practice:
ALLERGOLOGY INTERNATIONAL publishes articles that contribute to the development of clinical guidelines and best practices in allergology, enhancing the translation of research findings into clinical settings.
Trending and Emerging
- Biologics and Targeted Therapies:
There is a growing focus on biologic treatments for allergic diseases, particularly for severe asthma and chronic rhinosinusitis, reflecting advancements in precision medicine and personalized treatment strategies. - Microbiome and Allergic Diseases:
Emerging research on the gut microbiome's role in allergic diseases is becoming a prominent theme, with studies linking microbiota composition to the development and severity of allergies. - Patient-Centered Research:
An increasing number of studies are emphasizing patient-reported outcomes and quality of life in allergic disease management, highlighting the importance of patient perspectives in clinical research. - Environmental Factors and Allergies:
Research examining the impact of environmental exposures, such as air pollution and climate change, on the prevalence and severity of allergic diseases is gaining traction, reflecting a broader recognition of the role of the environment in health. - Genomic and Molecular Biomarkers:
The identification and validation of genomic and molecular biomarkers associated with allergic diseases are trending, enabling better prediction of disease progression and treatment response.
Declining or Waning
- Traditional Diagnostic Methods:
There seems to be a waning interest in traditional diagnostic approaches for allergies, such as skin prick tests, as newer, more precise diagnostic techniques are being developed and validated. - General Epidemiological Studies:
The frequency of general epidemiological studies focusing solely on prevalence rates of allergies without deeper insights into mechanisms or treatment efficacy has decreased, indicating a shift towards more targeted research. - Basic Immunology of Allergies:
There is a noticeable reduction in publications centered around basic immunological mechanisms of allergies, as the field moves towards more applied research that directly impacts clinical practice. - Non-specific Allergy Treatments:
Research on non-specific treatments for allergies, such as over-the-counter antihistamines, appears to be less frequent, possibly due to the rise of targeted therapies and biologics that offer more effective solutions.
Similar Journals
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
Exploring the frontiers of Allergy and Clinical Immunology.JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.
Postepy Dermatologii i Alergologii
Advancing knowledge in Dermatology and Allergy.Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.
Allergo Journal
Cultivating a deeper understanding of allergens.Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA
Connecting Researchers to Transform Allergy and Immunology InsightsALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.
AIMS Allergy and Immunology
Pioneering Insights for Immune HealthAIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.
Alergologia Polska-Polish Journal of Allergology
Advancing allergy research for a healthier tomorrow.Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.
ALLERGY
Illuminating Innovations in Allergy and Immunology.ALLERGY is a leading international journal published by WILEY, dedicated to advancing the understanding of allergic diseases and immunology. With an ISSN of 0105-4538 and an E-ISSN of 1398-9995, this esteemed journal has been at the forefront of the field since its inception in 1948 and continues to publish high-quality research up until 2024. Positioned in the Q1 category for both Immunology and Allergy, ALLERGY ranks impressively within the top percentiles of its categories, underscoring its significant impact, as reflected in its Scopus rankings (#11 out of 233 in Immunology and Allergy, and #14 out of 236 in Immunology and Microbiology). Researchers and practitioners accessing this journal can expect a rigorous selection of peer-reviewed articles that address current challenges, innovative therapies, and advancements in the immunological sciences. Although it is not an open-access journal, ALLERGY remains vital for academics, healthcare professionals, and students alike, fostering a deeper understanding of the mechanisms and treatments associated with allergies.
ALLERGOLOGIE
Exploring the Frontiers of Allergy and ImmunologyALLERGOLOGIE is a prominent academic journal dedicated to the field of immunology and allergy, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany. Since its inception in 1978, the journal has provided a vital platform for researchers, clinicians, and students to disseminate their findings, share insights, and foster advancements in the understanding of allergic diseases and immunological responses. With an ISSN of 0344-5062 and an E-ISSN of the same number, it is a respected source within its category, currently ranked in the 2023 Q4 of the Scopus metrics in immunology and allergy, reflecting its commitment to quality and scholarly rigor. Although not fully open access, ALLERGOLOGIE makes significant contributions to the dialogue on allergy-related topics, encouraging engagement from its readership through a diverse array of articles that span from clinical trials to innovative research methods. This journal continues to be an essential resource for anyone involved in the pursuit of knowledge in allergy and immunology.
CLINICAL AND EXPERIMENTAL ALLERGY
Unraveling the Complexities of Allergy ScienceCLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
Unveiling Breakthroughs in Allergy and Immunology.INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, published by KARGER, is a distinguished journal dedicated to advancing the field of immunology and allergy research. With an ISSN of 1018-2438 and an E-ISSN of 1423-0097, this journal has been a vital resource since its inception in 1950, continuing to publish influential articles through 2024. Hailing from Switzerland, it holds an important position within the Q3 category in Immunology and Allergy and Q2 in miscellaneous Medicine, reflecting its growing impact in the scientific community. The Scopus rankings showcase its relevance, with a 52nd percentile in Immunology and Allergy and 45th in Immunology and Microbiology. Although not an open-access journal, it plays a critical role in disseminating significant findings and innovations in the understanding of allergic diseases and immunological responses. The INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY is essential for researchers, clinicians, and students eager to stay at the forefront of allergy and immunology developments.